Fayyaz Mujtaba Profile
Fayyaz Mujtaba
Global Industry Analyst
Boston
1160370731

Insights By Fayyaz Mujtaba

Showing of Insights Posts
1073823296
Health care Thematic exposure Innovation iStrat Equity Disruption Article Global Industry Research
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Thematic investing focus: a new era for medical innovation

Advances in science, tools and technologies are transforming the face of healthcare, revolutionising the diagnosis and treatment of complex diseases. How can thematic investors identify promising opportunities?

Continue reading

Multiple authors

event
Article
2024-09-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
healthcare 2023 outlook
Health care Biotech Innovation Brand Economic cycle Equity Global Industry Research Article Outlook
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Health care outlook for 2023

Looking ahead to 2023, members of our health care team see meaningful innovation, supportive valuations, and a benign political and regulatory backdrop across biopharma, medical tech, and health care services sectors.

Continue reading

Multiple authors

event
Article
2023-12-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
2 LOAD {count} MORE

URL References

Related Insights

© Copyright 2024 Wellington Management International Ltd. All rights reserved.
WELLINGTON MANAGEMENT FUNDS ® is a registered service mark of Wellington Group Holdings LLP.
Wellington Management Singapore Pte. Ltd., a private limited company incorporated in the Republic of Singapore.
Licensed and regulated by the Monetary Authority of Singapore.
Address: 8 Marina Boulevard, Tower 1 #03-01 Marina Bay Financial Centre 018981.

For professional investors and intermediaries only. This content is not suitable for a retail audience.

View More